Search ARM

Myeloid Therapeutics is a clinical-stage, immune-cell programming company, focused on new treatment options for patients with solid tumors. The Company designs and deploys its proprietary mRNA-coded CARs for in vivo programming of immune cells.

Contact Myeloid Therapeutics
Visit Website